Maibu Robotics Raises Nearly 100M Yuan to Merge Brain-Computer Interfaces with Exoskeletons

Chinese exoskeleton robot maker Maibu Robotics has completed a nearly 100 million yuan strategic financing round led by CITIC Securities, becoming the first profitable company in the sector. The funds will support brain-computer interface integration and market expansion. Founded in 2016, Maibu focuses on rehabilitation for stroke and spinal cord injury patients. Its self-developed flexible actuators, validated in over 100 clinical cases at major hospitals, have driven repeat hospital purchases and established a strong patent moat with 200-plus patents. The company appointed former Johnson & Johnson executive Chen Kangning as CEO to strengthen commercialization. Future priorities include brain-computer interface clinical translation, expanding products across hospital-community-home settings, and international growth, aiming to scale "intention-driven rehabilitation" from lab to widespread use.